Infectious Disease Therapies Research and Innovation Act of 2022

Cost and committee reports

Official records Congress.gov attaches to H.R. 7515.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. KELLY of Pennsylvania, as printed in the Congressional Record (Vol. 168, No. 64, April 14, 2022, Page H4444):
  Article 1, Section 8, Clause 3 of the U.S. Constitution
  Source: Congress.gov, Congressional Record April 14, 2022 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  55 characters

  Congress.gov bill record

  H.R. 7515, 117th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/117/hr/7515

  Record last updated by Congress.gov

  January 3, 2025

  PORKER copy retrieved

  September 16, 2026

  Stored copy, SHA-256 of the file

  e69ab941f475a45141f88234373b5ce46fc608b52c0f0b50626d6db80113e68f

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of January 3, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 7515, last updated January 3, 2025. PORKER’s copy was retrieved September 16, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.